Menu Close

Articles on AstraZeneca

Displaying 21 - 40 of 47 articles

The number one scientific breakthrough for 2020: multiple vaccines to prevent COVID-19. Philippe Raimbault/Photodisc via Getty Images

The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines

The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Tony Potts, a 69-year-old retiree, removes his face mask for a temperature check just before receiving his first injection in a phase 3 COVID-19 vaccine clinical trial sponsored by Moderna. Potts is one of 30,000 participants in the Moderna trial. Paul Hennessy/NurPhoto via Getty ImageS

What are emergency use authorizations, and do they guarantee that a vaccine or drug is safe?

The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y. (AP Photo/Hans Pennink, File)

COVID-19 vaccine FAQ: 6 things to look for in clinical trial results

With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Pfizer stock surged higher on Nov. 9 after the company announced its vaccine is “90% effective” against COVID-19 infections. KENA BETANCUR/AFP via Getty Images

Why we didn’t get a vaccine by Election Day – but why we may get one soon

With COVID-19 cases soaring across the US and worldwide, the need for a vaccine could not be greater. Here's where we stand on vaccine development, including positive results from Pfizer's trial.

Top contributors

More